Independent Director · DiaMedica Therapeutics Inc. (DMAC)

Chair, Nominating/Governance Committee

Michael Giuffre, M.D director compensation at DiaMedic (FY2025): $148K

Fiscal year 2025 director compensation for Michael Giuffre, M.D at DiaMedica Therapeutics Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 1, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Michael Giuffre, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael Giuffre, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

DiaMedica Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as DiaMedica Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$58,000$1,844$88,574$0$148,418
FY2023$53,750$0$37,175$0$90,925
FY2021$57,777$13,395$26,906$0$98,078

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DiaMedica Therapeutics Inc. DEF 14A filed April 1, 2026, accession 0001437749-26-010879, and prior-year filings. Open the filing on EDGAR.

How this page was built: the DiaMedica Therapeutics Inc. filed document, accession 0001437749-26-010879. Every figure is read from that document and cited to the page and table it appears in. Filed April 1, 2026.

Get the DiaMedica Therapeutics Board Governance Report

$148,418 Michael Giuffre, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 1, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

DiaMedica Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance (Chair) · Scientific & Clinical Research

The rest of the DiaMedica Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Charles Semba, M.DIndependent Director$145,972
Daniel O’ConnorIndependent Director$358,273
James ParsonsChair of the Board$199,898
Richard Kuntz, M.DIndependent Director$143,261
Rick PaulsDirector—
Tanya LewisIndependent Director$141,574

The full DiaMedica Therapeutics compensation record

free company brief

This page is one director within DiaMedica Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the DiaMedica Therapeutics proxy · each links to its own free brief

Order DMAC

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report